Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine

NCT01405677 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

308

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis A

Interventions

BIOLOGICAL: Epaxal 0.25 mL
BIOLOGICAL: Epaxal 0.5 mL
BIOLOGICAL: Havrix Junior 0.5 mL

Sponsor

Crucell Holland BV